News for Research Solutions, Inc. (RSSS)

PR NewswireHENDERSON, Nev., March 10, 2025 New Solution Supports Growing Demand for AI-Enabled Research & Development Market, Enabling Research Efficiency

Texas-based Moleculin Biotech, Inc. (MBRX), a clinical stage pharmaceutical company is up over 53 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Research Solutions (RSSS) reports record ARR growth, AI-driven platform enhancements, and strategic sales restructuring in Q2 2025.

Research Solutions, Inc. (NASDAQ:RSSS) Q2 2025 Earnings Conference Call February 13, 2025 5:00 PM ETCompany ParticipantsSteven Hooser - Investor...

Research Solutions Inc (RSSS) is set to release its Q2 2025 earnings on Feb 13, 2025. The consensus estimate for Q2 2025 revenue is $11.83 million, and the earn

Research Solutions (RSSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

We recently published a list of 12 Must-See AI News and Ratings You Might Have Missed. In this article, we are going to take a look at where Research Solutions, Inc.

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a [url="]new way[/url] to provide genetic couns

Here is how Research Solutions Inc. (RSSS) and ScanSource (SCSC) have performed compared to their sector so far this year.

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

Research Solutions (RSSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

On November 15, 2024, Cove Street Capital, LLC (Trades, Portfolio) made a strategic decision to reduce its position in Research Solutions Inc (RSSS). The firm d

PR NewswireHENDERSON, Nev., Nov. 19, 2024 SaaS Executive with Track Record of Accelerating GrowthHENDERSON, Nev., Nov. 19, 2024 /PRNewswire/ -- Research So

Research Solutions, Inc. (NASDAQ:RSSS) Q1 2025 Earnings Conference Call November 14, 2024 5:00 PM ETCompany ParticipantsSteven Hooser - IRRoy Olivier -...

Operator: To all sites on hold, we do appreciate your patience in holding and ask that you please continue to stand by. We will begin in approximately two minutes. Thanks again, everyone.

These stocks are making interesting moves on high volume. Active Stocks Moving Up Today QuickLogic Corporation (QUIK) < (QUIK) is currently trading at $6....

German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker

Update on Ongoing Matters at AnalytixInsight

For Q4 2023, an average partnership interest in Artko Capital LP was up 6.9% net of fees. Click here to read the full fund letter.